Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
accelerated approval
Pharma
FDA advisers back new endpoint for myeloma approvals
After experts reviewed arguments in favor of a surrogate endpoint to support approvals, myeloma drug developers may soon have a new R&D pathway.
Angus Liu
Apr 12, 2024 4:06pm
FDA weighs another approvable myeloma endpoint. What's at stake?
Apr 9, 2024 9:00am
Many meds couldn't prove benefits after speedy FDA nods: study
Apr 8, 2024 6:30pm
Amylyx to pull failed ALS drug from market, cut 70% of staff
Apr 4, 2024 10:06am
BMS touts KRAS confirmatory trial win after Amgen's stumble
Mar 29, 2024 10:35am
FDA revokes approval of Oncopeptides' Pepaxto
Feb 23, 2024 11:10am